Novartis

Member of UN Global Compact

Headquarters in Switzerland

Novartis website

🔎 Run a search for “Novartis”

Get RSS feed of these results

All stories

Article
25 June 2014

Novartis convenes 13th annual malaria expert panel with a focus on access to quality antimalarials across Africa

Author: African Press Organization

There is a need for quality-assured antimalarial treatments in both the private and public sectors…Half of patients in Africa buy antimalarials from the private sector…where wide availability of sub-standard treatment is putting patients’ lives at...

Read more

Article
1 May 2014

[PDF] Evidence of Corporate Disclosure relevant to the UN Guiding Principles on Business and Human Rights

Author: Shift

This research was conducted to inform understanding of how companies currently report on their human rights performance, and how this maps against the UN Guiding Principles on Business & Human Rights. The research reviewed corporate disclosure of...

Read more

Lawsuit
26 March 2014

Novartis lawsuit (re India patent law & access to medicine)(new)

Author: Business & Human Rights Resource Centre

Worldwide, Novartis is the main producer of Glivec, a drug used for treating blood cancer.  The company has sought a patent that would give it the exclusive right to produce Glivec, stopping production by the generic drugs industry in India.  ...

Read more

Story
25 March 2014

Novartis lawsuit (re India patent law & access to medicine)

Worldwide, Novartis is the main producer of Glivec, a drug used for treating blood cancer.  The company has sought a patent that would give it the exclusive right to produce Glivec, stopping production by the generic drugs industry in India.  ...

See full story

Article
19 February 2014

Allegations of pharmaceutical group's planned opposition to So. Africa reforms to increase access to medicines - company responses/non-responses

Author: Business & Human Rights Resource Centre

In January 2014, the Innovative Pharmaceutical Association of South Africa (IPASA) was accused of planning and funding an advocacy campaign on behalf of its member companies. The campaign allegedly sought to oppose South Africa’s efforts to introduce...

Read more

Company response
19 February 2014

Response by Novartis: Allegations of pharmaceutical group's planned opposition to So. Africa reforms to increase access to medicines

Read full response

Story
17 February 2014
+ Español - Hide
Article
17 February 2014
+ Español - Hide

Author: Fundación Ideas para la Paz (Colombia)

En 2011…un grupo de empresas suizas que operan en Colombia se reunieron con el fin de formalizar su compromiso respecto a la integración a su gestión, de los Derechos Humanos (DDHH) y el Derecho Internacional Humanitario (DIH)…[En 2012] las empresas...

Read more

Article
6 January 2014

To patent or not to patent? the case of Novartis’ cancer drug Glivec in India

Author: Ravinder Gabble & Jillian Clare Kohler, in Global Health (USA)

Glivec...produced by the pharmaceutical company Novartis, is prescribed [to treat]...one of the most common blood cancers in eastern countries...[T]he Supreme Court of India gave its final decision...rejecting the appeal of the Swiss...drug...

Read more

Article
1 January 2014

[PDF] Corporate influence in the Post-2015 process

Author: Lou Pingeot, Global Policy Forum

[T]his working paper examines the role and influence of business actors in the process towards the Post-2015 agenda of the UN, with particular attention to the influence of large transnational corporations. The business sector certainly has an...

Read more